Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia Redazione 21 Gennaio 2021 ...
The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing Redazione 21 Gennaio 2021 ...
Phase 2 study of lenalidomide maintenance for patients with high‐risk acute myeloid leukemia in remission Redazione 21 Gennaio 2021 ...
Brief Report: CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia Redazione 21 Gennaio 2021 ...
Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease Redazione 21 Gennaio 2021 ...
Autologous stem cell transplantation finds a place in acute promyelocytic leukaemia Redazione 21 Gennaio 2021 ...
Reporting Clinical Studies Affected by the COVID-19 Pandemic: Guidelines for Authors Redazione 21 Gennaio 2021 ...
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric‐like GIMEMA LAL‐1308 trial Redazione 14 Gennaio 2021 ...
Creating an international network for science and clinical progress: democratizing dissemination of advances in global hematology Redazione 14 Gennaio 2021 ...